Modified Rice Bran May Treat HIV

Modified Rice Bran May Treat HIV

NEW ORLEANS--In a study that was presented March 25 at the 92nd Annual American Academy of Cancer Research(AACR) held here, researchers reported that MGN-3, which is a patented constituent of rice bran modified with Shiitake mushroom enzymes, may offer therapeutic effects for HIV. The in vitro study, led by Mamdooh Ghoneum from Charles Drew University and the University of California, Los Angeles, was conducted on breast cancer cells. The researchers found that MGN-3 suppressed cancer growth during a 16-hour incubation period. This constituent has previously been found to increase the activity of immune cells, including T-cells, without producing toxic reactions. This study was sponsored by Allendale, N.J.-based Lane Labs, which manufactures MGN-3. For additional information, visitwww.publishedresearch.com.